losartan has been researched along with bucladesine in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Franco-Saenz, R; Mulrow, PJ; Yamaguchi, T | 1 |
Ball, DL; Elliott, ME; Goodfriend, TL; Jefcoate, CR | 1 |
Anand-Srivastava, MB; Li, Y | 1 |
4 other study(ies) available for losartan and bucladesine
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Effect of angiotensin II on renin production by rat adrenal glomerulosa cells in culture.
Topics: Adrenocorticotropic Hormone; Aldosterone; Angiotensin II; Animals; Biphenyl Compounds; Bucladesine; Cells, Cultured; Cyclic AMP; Female; Imidazoles; Losartan; Potassium; Rats; Rats, Inbred Strains; Renin; Tetrazoles; Zona Glomerulosa | 1992 |
Angiotensin-responsive adrenal glomerulosa cell proteins: characterization by protease mapping, species comparison, and specific angiotensin receptor antagonists.
Topics: Aldosterone; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Biphenyl Compounds; Bucladesine; Cattle; Cells, Cultured; Chymotrypsin; Imidazoles; Losartan; Male; Methionine; Peptide Mapping; Protein Biosynthesis; Proteins; Pyridines; Rats; Rats, Sprague-Dawley; Species Specificity; Sulfur Radioisotopes; Tetrazoles; Zona Glomerulosa | 1997 |
Implication of multiple signaling pathways in the regulation of angiotensin II induced enhanced expression of Giα proteins in vascular smooth muscle cells.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Animals; Bucladesine; Calcium; Cell Line; Chelating Agents; Dactinomycin; Drug Interactions; Egtazic Acid; Estrenes; Gallic Acid; Gene Expression Regulation; Genistein; GTP-Binding Protein alpha Subunits, Gi-Go; Imidazoles; Losartan; Nucleic Acid Synthesis Inhibitors; Protein Kinase Inhibitors; Pyridines; Pyrrolidinones; Rats; Signal Transduction; Type C Phospholipases | 2012 |